Valuation for Neurones (id:10702 NRO)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 22.71 |
|
|
| Forward P/E | 20.55 |
|
|
| Price to sales | 1.45 |
|
|
| Price to book | 3.14 |
|
|
| Enterprise to revenue | 1.19 |
|
|
| Enterprise to ebitda | 11.25 |
|
|